Biobehavioral Bases & Management of Metabolic Syndrome
生物行为基础
基本信息
- 批准号:7248203
- 负责人:
- 金额:$ 52.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Atherogenic DietAutomobile DrivingBehaviorBehavior TherapyBehavioralBiochemicalBlood PressureBlood VesselsBody Weight decreasedCardiacCardiovascular DiseasesCardiovascular systemCaringCentral obesityClinicClinicalClinical MarkersCoagulation ProcessCommunity HealthCommunity Health CentersCoping SkillsCoronary heart diseaseDevelopmentDiabetes MellitusDisadvantagedDiseaseDyslipidemiasEducationEducational CurriculumEpidemicEthnic groupExerciseFamily PracticeFastingFrequenciesFunctional disorderGlucoseGlucose IntoleranceGoalsHealthHigh Density Lipoprotein CholesterolHispanicsHyperlipidemiaIndividualInflammationInflammatoryInsulinInsulin ResistanceInterventionLatinoLifeLife StyleLipidsLipoproteinsLongitudinal StudiesLow incomeMaintenanceMatched GroupMeasurementMeasuresMetabolicMetabolic syndromeMinority GroupsModificationMorphologyNon-Insulin-Dependent Diabetes MellitusNumbersObesityOutcomeOutcome MeasureOxidative StressParticipantPathogenesisPatientsPhasePhase II Clinical TrialsPhysical activityPlayPopulationPrevalenceProcessProfessional counselorProtocols documentationPsychosocial Assessment and CareQuality of lifeRandomizedRandomized Clinical TrialsRateRecommendationRiskRisk FactorsRoleRunningSeveritiesSocial EnvironmentSocietiesStandards of Weights and MeasuresStructureSyndromeThinkingTriglyceridesVisitWalkingWeekWeightWeight GainWorkbasebiobehaviorcardiovascular disorder riskdata managementdiabetes riskdietary restrictioneligible participantexperienceglycemic controlheart disease riskimprovedinner cityinsulin sensitivityintervention programlifestyle interventionmemberminority subjectsmultidisciplinarypreclinical studyprogramspsychosocialsedentarysocioeconomicsstress managementwaist circumference
项目摘要
About 25% of the population in the US have the metabolic syndrome, a cluster of cardiovascular disease
(CVD) risk factors including abdominal obesity, glucose intolerance, elevated blood pressure and
dyslipidemia, and this prevalence is even higher in low income groups. The presence of this syndrome
increases risk for diabetes by 3-fold and for CVD approximately two-fold. Since obesity, sedentary living and
an atherogenic diet are believed to play major roles in the development of the metabolic syndrome, lifestyle
modification is considered to be the primary approach to its treatment, although there have been few longterm
studies of the efficacy of such programs. This project will compare the effects of a 1-year, structured
lifestyle intervention program (Enhanced Care [EC]) in 112 patients (80 completers) with the metabolic
syndrome attending an inner city family medicine clinic to that of a matched group receiving standard lifestyle
recommendations (Standard Care [SC]) in a randomized clinical trial. By structuring the lifestyle program to
modify behavior and improve coping skills, it is predicted that participants will reduce weight by 7% and
increase physical activity by at least 150 minutes per week of walking-style exercise. The EC protocol will
consist of 4 weekly followed by 4 bi-weekly group sessions making up the Core Curriculum during the first 3
months, followed by 9 monthly Maintenance group sessions, and will be delivered by experienced lifestyle
managers with expertise in behavior modification among low-income people as well as in subjects from
minority ethnic groups. Assessments of metabolic syndrome components, weight, physical activity, health
quality of life, psychosocial status, glucose, insulin and lipid and lipoprotein levels, markers of inflammation,
coagulation, oxidative stress and endothelial dysfunction, and subclinical CVD measures, will be undertaken
at baseline, 6, and 12 months, since it is anticipated that the EC intervention will improve CVD risk factors
and reduce the prevalence and intensity of the metabolic syndrome and the pathophysiological factors
driving it. This study is intended to demonstrate that a structured program directed at weight reduction and
increasing physical activity can be successfully applied to low income patients with the metabolic syndrome.
Reducing the frequency and the severity of the metabolic syndrome through effective weight reduction and
increased phsycial activity is expected to lower the rate of diabetes and cardiovascular disease in the long
term.
在美国,大约25%的人患有代谢综合征,这是一组心血管疾病
(CVD)危险因素包括腹部肥胖、葡萄糖耐受不良、血压升高和
血脂异常,这种患病率在低收入群体中甚至更高。这种综合症的出现
糖尿病风险增加3倍,CVD风险增加约2倍。由于肥胖,久坐不动的生活和
致动脉粥样硬化的饮食被认为在代谢综合征、生活方式、
修改被认为是其治疗的主要方法,尽管很少有长期的
研究这些方案的有效性。本项目将比较一个为期一年的,结构化的
在112例代谢性疾病患者(80例完成者)中实施生活方式干预计划(增强型护理[EC]),
与接受标准生活方式的匹配组相比,
推荐(标准治疗[SC])。通过构建生活方式计划,
改变行为并提高应对技能,预计参与者将减轻7%的体重,
每周至少增加150分钟的步行运动。EC方案将
包括4个每周一次,然后是4个双周一次的小组会议,构成了前3个月的核心课程。
个月,然后是9个月的维护小组会议,并将提供经验丰富的生活方式
管理人员在低收入人群中的行为矫正方面具有专业知识,
少数民族群体。评估代谢综合征组分、体重、体力活动、健康
生活质量、心理社会状态、葡萄糖、胰岛素和脂质及脂蛋白水平、炎症标志物,
将进行凝血、氧化应激和内皮功能障碍以及亚临床CVD测量
在基线、6个月和12个月时,因为预期EC干预将改善CVD风险因素
降低代谢综合征的患病率和严重程度,
这项研究的目的是证明,一个结构化的计划,针对减轻体重,
增加身体活动可以成功地应用于患有代谢综合征的低收入患者。
通过有效的减肥降低代谢综合征的频率和严重程度,
长期以来,增加身体活动有望降低糖尿病和心血管疾病的发病率。
term.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronald B Goldberg其他文献
Ronald B Goldberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronald B Goldberg', 18)}}的其他基金
Biomarkers and Outcomes in the Diabetes Prevention Program
糖尿病预防计划中的生物标志物和结果
- 批准号:
7821189 - 财政年份:2008
- 资助金额:
$ 52.73万 - 项目类别:
Biomarkers and Outcomes in the Diabetes Prevention Program
糖尿病预防计划中的生物标志物和结果
- 批准号:
7610881 - 财政年份:2008
- 资助金额:
$ 52.73万 - 项目类别:
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 – Research Project
04/22 糖尿病预防计划成果研究 (DPPOS) 第 3 阶段 — 研究项目
- 批准号:
9319872 - 财政年份:1994
- 资助金额:
$ 52.73万 - 项目类别:
相似海外基金
Establishment of a method for evaluating automobile driving ability focusing on frontal lobe functions and its application to accident prediction
以额叶功能为中心的汽车驾驶能力评价方法的建立及其在事故预测中的应用
- 批准号:
20K07947 - 财政年份:2020
- 资助金额:
$ 52.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Evaluation of the Effectiveness of Multi-Professional Collaborative Assessment of Cognitive Function and Automobile Driving Skills and Comprehensive Support
认知功能与汽车驾驶技能多专业协同评估效果评价及综合支持
- 批准号:
17K19824 - 财政年份:2017
- 资助金额:
$ 52.73万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of Flexible Automobile Driving Interface for Disabled People
残疾人灵活汽车驾驶界面开发
- 批准号:
25330237 - 财政年份:2013
- 资助金额:
$ 52.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Automobile driving among older people with dementia: the effect of an intervention using a support manual for family caregivers
患有痴呆症的老年人的汽车驾驶:使用家庭护理人员支持手册进行干预的效果
- 批准号:
23591741 - 财政年份:2011
- 资助金额:
$ 52.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




